M.A. Valantin

1.1k citations
27 papers · 484 · h-index 13

Impact in

Papers in

    • HIV/AIDS drug development and treatment 17
    • HIV/AIDS Research and Interventions 12
    • HIV, Drug Use, Sexual Risk 5
    • Pneumocystis jirovecii pneumonia detection and treatment 4

M.A. Valantin

24 papers receiving 468 citations

Peers

M.A. Valantin
Comparison fields: 5 of 54
  • Virology 159
  • Hepatology 131
  • Infectious Diseases 305
  • Emergency Medicine 99
  • Epidemiology 216
Replace Maria Martínez‐Rebollar with:
Maria Martínez‐Rebollar Spain
Charles Béguelin Switzerland
Amélie Menard France
Thérèse Staub Luxembourg
Monika Bociąga‐Jasik Poland
A. Cargnel Italy
Leire Pérez‐Latorre Spain
Sivaporn Gatechompol Thailand
Núria Espinosa Spain
Roberta Gagliardini Italy
M.A. Valantin relative to Maria Martínez‐Rebollar Spain Maria Martínez‐Rebollar's profile →
Citations per field
00.5×1.5×
Maria Martínez‐Rebollar · 1×
Citations per year

Countries citing papers authored by M.A. Valantin

Since Specialization
Citations

This map shows the geographic impact of M.A. Valantin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Valantin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Valantin more than expected).

Fields of papers citing papers by M.A. Valantin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Valantin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Valantin. The network helps show where M.A. Valantin may publish in the future.

Co-authors

The 25 scholars most cited alongside M.A. Valantin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M.A. Valantin Line = papers co-authored together M.A. Valantin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200997
2 200484
3 201360
4 201634
5 201530
6 201526
7 201822
8 202220
9 201818
10 200817
11 201016
12 201214
13 201913
14 20218
15 20178
16 20095
17 20093
18 20163
19 20241
20 20151

About M.A. Valantin

M.A. Valantin is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Emergency Medicine, having authored 27 papers that have together received 484 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (10 papers), Hepatitis C virus research (8 papers), HIV-related health complications and treatments (7 papers), HIV, Drug Use, Sexual Risk (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Virology (159 citations), Hepatology (131 citations), Infectious Diseases (305 citations), Emergency Medicine (99 citations) and Epidemiology (216 citations). M.A. Valantin has collaborated with scholars based in France, Martinique and Tunisia. Frequent co-authors include Christine Katlama, Roland Tubiana, André Cabié, Clotilde Allavena, Isabelle Poizot‐Martin, P. Puglièse, Anne Simon, Claudine Duvivier, Stéphanie Dominguez and Jade Ghosn. Their work appears in journals such as HIV Medicine, Journal of Antimicrobial Chemotherapy, International Journal of STD & AIDS, Journal of Hepatology and Journal of the International AIDS Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact